Sofinnova Investments, Inc. - Q1 2023 holdings

$1.56 Billion is the total value of Sofinnova Investments, Inc.'s 53 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .

 Value Shares↓ Weighting
OBSV ExitObsEva SA$0-4,749,623
-100.0%
-0.04%
CTIC ExitCTI Biopharma Corpcall$0-410,000
-100.0%
-0.15%
AGEN ExitAgenus Inccall$0-1,267,000
-100.0%
-0.18%
CYTK ExitCytokinetics Inccall$0-100,000
-100.0%
-0.27%
FULC ExitFulcrum Therapeutics Inc$0-631,411
-100.0%
-0.27%
GERN ExitGeron Corpcall$0-2,369,100
-100.0%
-0.34%
RCUS ExitArcus Biosciences Inc$0-314,811
-100.0%
-0.39%
ALGN ExitAlign Technology Inc$0-83,100
-100.0%
-1.04%
ALNY ExitAlnylam Pharmaceuticals Inccall$0-100,000
-100.0%
-1.41%
UTHR ExitUnited Therapeutics Corp$0-89,207
-100.0%
-1.47%
AZN ExitAstraZeneca PLCsponsored adr$0-613,673
-100.0%
-2.47%
VRTX ExitVertex Pharmaceuticals Inc$0-156,989
-100.0%
-2.69%
ExitCincor Pharma Inc$0-6,073,949
-100.0%
-4.43%
SNY ExitSanofi SAsponsored adr$0-1,965,475
-100.0%
-5.65%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Natera, Inc.23Q3 202320.5%
Ascendis Pharma A/S23Q3 202327.9%
NuCana plc23Q3 202315.2%
Synlogic Inc. (fmrly Mirna)22Q2 20230.9%
Y-mAbs Therapeutics, Inc.21Q3 20236.5%
ObsEva SA20Q4 202211.0%
Nucana PLC19Q3 20239.7%
SYNDAX PHARMACEUTICALS INC19Q3 20232.2%
PDS Biotechnology Corporation19Q3 20230.1%
Karuna Therapeutics, Inc.18Q3 202327.1%

View Sofinnova Investments, Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Sofinnova Investments, Inc. Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
OTONOMY, INC.Sold outFebruary 14, 202200.0%

View Sofinnova Investments, Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-11
13F-HR2023-02-14
13F-HR2022-11-08
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
SC 13G/A2022-02-14

View Sofinnova Investments, Inc.'s complete filings history.

Compare quarters

Export Sofinnova Investments, Inc.'s holdings